In IMQ-induced psoriasis reported here, inhibition of IL-18Rα exacerbated skin lesions, suggesting that the signaling pathway induced by IL-18Rα may suppress the innate immune response, mainly neutrophil-mediated response in this dermatitis. The gene discussed is IL18R1; the disease is dermatitis.